A Potential Laboratory Test for Dysplastic Nevus Syndrome: Ultraviolet Hypermutability of a Shuttle Vector Plasmid  by Moriwaki, Shin-Ichi et al.
REPORTS 
A Potential Laboratory Test for Dysplastic Nevus 
Syndrome: Ultraviolet Hypermutability 
of a Shuttle Vector Plasmid 
Shin-Ichi Moriwaki, Robert E. Tarone,* and Kenneth H. Kraemer 
Laboratory of Molecular Carcinogenesis and 'Biostatistics Branch, National Cancer Institute, Bethesda, Maryland, U.S.A. 
The diagnosis of the melanoma-prone disorder dysplastic 
nevus syndrome (ONS) is based currently on a combination 
of clinical and histopathologic examinations of patients. To 
develop a potential laboratory test for ONS, we utilized the 
observation that an ultraviolet light (UV)-treated mutagene-
sis plasmid shuttle vector has an abnormally increased fre-
quency of mutations after transfection into lymphoblastoid 
cells from a patient with familial ONS. pSP189 (containing 
the bacterial suppressor tRNA gene supF as a marker for 
mutations and a gene for ampicillin resistance for selection) 
was treated with UV and transfected into familial ONS, xero-
derma pigmentosum complementation group A (XP-A), and 
normallymphoblastoid cells by electroporation or diethyla-
minoethyl (OEAE) dextran. Untreated plasmid pZ189K 
(containing a gene for kanamycin resistance) was co-trans-
fected as an internal standard to reduce the variability of 
plasmid survival measurements. After 2 d, plasmids were 
F amiJial dysplastic nevus syndrome (0 NS) is an autosomal dominant disease characterized clinically by multiple morphologically atypical moles, which are more irregu-lar and often larger than common pigmented nevi [1,2]. These lesions are both markers of people with increased 
risk of malignant melanoma and precursors of melanoma [1]. Histo-
logically, dysplastic nevi (ON) have nuclear atypia and a disorderly 
growth pattern of melanocytes [3,4]. At present the diagnosis of 
ONS (familial or non-familial) is based on the clinical features and 
histologic findings. However, there is a lack of agreement among 
pathologists because cases of clinical ONS without typical histo-
logic abnormalities and cases of common acquired nevi with patho-
logic findings similar to ON have been reported [5 - 7]. Establish-
ment of a definite diagnosis of familial ONS using laboratory tests 
should be of assistance in assessing melanoma risk in the estimated 
8-12% of melanomas that are familial [2,8,9] and may also be 
useful in evaluating the melanoma risk in patients with non-familial 
ONS [9]. 
Ultraviolet (UV) radiation appears to play a role in melanoma 
induction. There is clinical evidence for sun sensitivity in patients 
with ONS [10,11]. Some [12-14] but not all [15,16] cultured fibro-
blasts or Epstein-Barr virus (EBV) - transformed lymphoblastoid 
cells from patients with ONS are hypersensitive to killing by UV. 
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extracted, used to transform an indicator strain of Escherichia 
coli, and assayed on plates containing ampicillin or kanamy-
cin. Counting light blue or white colonies (containing mu-
tated supF in the plasmid) and blue colonies (with wild type 
supF) permitted measurement of the plasmid survival and 
mutation frequency. Transfection by electroporation or 
OEAE dextran resulted in abnormally reduced survival of 
UV -treated plasmid after passage through the XP-A but 
normal survival in the three ONS lines. Transfection ofUV-
treated plasmid by DEAE dextran yielded a greater hyper-
mutability with the familial ONS lines than by electropora-
tion. These results suggest that pSP189 UV hypermutability 
with normal UV survival using DEAE dextran transfection 
may form the basis of a potential laboratory assay for familial 
ONS. Key words: melanoma/DNA repair/transfection/lympho-
blastoid cells. ] Invest Dermatol1 03:7 -12, 1994 
However, cells from ONS patients are hypermutable to UV [13,16] 
and show abnormally elevated rates of sister chromatid exchanges 
after UV exposure [17]. 
Shuttle vector plasmids have been used recently to study muta-
genesis by UV in human cells [18 -29]. Seetharam et al [30] reported 
UV hypermutability with normal UV survival of a shuttle vector 
plasmid, pZ189, passed through the EBV-transformed lymphoblas-
toid cells from a patient with ONS. These results suggested that 
plasmid UV hypermutability might form the basis of a potential 
laboratory test for the diagnosis of ONS. 
MATERIALS AND METHODS 
Cells Lymphoblastoid cell lines were established by EBV transformation 
of blood lymphocytes from three patients with familial DNS (DNS3BE, 
DNSSBE = GM06921 , and DNS6BE) [16], a patient with xeroderma pig-
mentosum (XP) group A (XP12BE = GM022S0) [31], and four normal 
individuals (GM606, KR6057, KR6058, and KR6060). Lines designated 
GM or KR were transformed at the Institute for Medical Research, Camden, 
NJ. Cells were cultured in RPMl1640 (Gibco, BRL, Bethesda, MD) me-
dium supplemented with lS% fetal bovine serum (S&S Media, Rockville, 
MD) and 2 rnM L-glutamine (Gibco, BRL) at 37°C in a S% CO2 atmo-
sphere as described [16]. 
Plasmid and UV Irradiation The structure of the three approximately 
S.S-kilobase pair (kbp) shuttle vector plasmids used in this study are dia-
grammed in Fig 1. All contain the same SV40 origin of replication, en-
hancer, and large-T antigen sequences that permit replication in human cells 
[18]. All contain the replication origin from pBR327 that permits replication 
in bacteria, an approximately ISO-base pair (bp) bacterial stlpF suppressor 
tRNA gene as a marker for mutations [19], and a gene for antibiotic resist-
ance to permit selection in bacteria [18]. The parental plasmid, pZ 189 [18] 
contains the gene for ampicillin resistance. pZ 189K was a generous gift from 
Dr. Steven Akman, City of Hope, Duarte, CA, who constructed the plasmid 
0022-202X/94/S07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
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Figure 1. Schematic diagram of shuttle vector plasmids used in these stud_ 
ies. All three -5.5-kbp plasmids (pZ189. pZ189K, and pSP189) contain the 
same simian virus 40 (SV 40) sequences (origin of replication, tori], enhancer, 
and Iarge-T antigen) that permit replication in huma~ cells, the pBR3~7 
origin of replication that permits replication 111 bactena and the bacten~l 
sllpF suppressortRNA that serves as a target for mutations [18] . The bacteri~l 
genes for ampici llin resistance (ampR) (pZ.189and pSP189) or kanamy~ln 
resistance (kanR) (pZ189K) serve for selectIOn 111 ?acten~. pSP189 contalll.s 
an 8-bp random "signature" (sig) sequence and IS mlss1l1g a sequence be_ 
tween the ampR gene and the supF gene [32]. 
by inserting the gene for kanamycin resistance in place of the ge?e fClr 
ampicillin resistance in pZ189. pSP189, constructed by Pams and. Seidman 
[32] contains the gene for ampicillin resistance, an 8-bp random "signature" 
sequence that distinguishes siblings from independeI?-t mutants and lacks a 
region present in pZ 189 between the gene for ampiCillin resistance and t!-te 
StlpF marker gene. 
Plasmids pSP189 or pZ 189 in water at a concentration of 31 Jig/ml wete 
irradiated on ice as described [24] using a germicidal lamp (General Electric 
G15T8) (predominantly 254 nm) at a rate of 1.5 J/m2/second, as measured 
with an International Light Company IL770A Research RadIOmeter. Non_ 
irradiated plasmid pZ189K was used as an internal standard. The number of 
cyclobutane dimer photoproducts produced in the plasmid DNA using t!-tis 
treatment was measured by assessing the extent of nicking (loss of supercoil-
ing) by T4 endonuclease V (a gift from Dr. R. Stephen Lloyd of Galveston, 
TX) of UV -treated plasmids, as previously described [33,34). ThiS enzY~e 
specifically nicks DNA at cyclobutane dimers and the loss of sup.ercollill.g 
(analyzed on agarose gels) is an extremely sensitive assay for ruck1l1g of 
plasmids. We quantitated the extent of supercoiling by use of a Molecular 
Dynamics laser densitometer to scan a negative photograph of the geL We 
found that the Do (the slope of the curve of relative loss of supercOilill.g 
versus UV dose, a measure of the dose that produces one cyclobutane dim.er 
photoproduct per plasmid) was 14 J' m- 2 for pBR322 (4.3 kbp), a value 
similar to that reported previously [33.34). This corresponds to a Do oft 1 for 
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pSP189 (5.5 kbp). Thus one cyclobutane dimer photoproduct is produced in 
the plasmid for each 11 J' m- 2 UV exposure to pSP189. 
Transfection 
Electroporatioll: Transfection by electroporation was performed using a 
Biorad Gene Pulser (Biorad Inc.) as described (24). Briefly, 30 X 106 rapidly 
growing cells in serum-free RPMI 1640 medium were placed into a Biorad 
e1ectroporation chamber cuvette (O.4-cm gap) with 5 Ilg of UV-treated 
pSP189 and 5 J1g of nonexposed pZ189K in a total volume of 0.5 m!. After 
cooling on ice for 5 min. each sample was pulsed once with 200 V with a 
capacitance setting of960 IlF. The cuvettes were placed on ice for a further 5 
min and the cell-DNA mixtures were suspended in 40 ml of growing me-
dium. 
DEAE Dextrall: Plasmids were transfected by use of DEAE dextran (Phar-
macia, Fine Chemicals, Uppsala, Sweden) using a modification of the proce-
dure described previously [30). One microgram of UV-treated plasmid 
pSP189 or pZ189 were mixed with l/lg of nonirradiated pZ189Kand added 
to 30 X 106 exponentially growing cells in 1 ml medium containing 500 J1g 
DEAE dextran. After 10 min at 37 °C in the 5% CO2 incubator, the cell-
DNA-DEAE dextran mixture was washed by dilution in 15 ml medium, 
centrifuged at 800 rpm for 5 min, and diluted into 40 ml medium for further 
culture. 
Recovery of Plasm ids and Selection of Mutants Purification of repli-
cated plasmids from the human cells and transformation of bacteria by elec-
troporation were performed as described [24]. After 2 d incubation the 
plasmids were extracted from the human cells and digested with the restric-
tion enzyme DpnI (Biolabs) to remove umeplicated plasm ids with the bac-
terial methylation pattern. The replicated plasmids were used to transform 
competent MLBI00, a strain of E. coli, with an amber mutation in the lacZ 
gene using electroporation [24]. Forty microliters of competent bacteria 
were placed into a Biorad cuvette (0.2 cm gap) on ice with 4.5/11 of15 III Hirt 
extracts in Tris-ethylenediamine tetraacetic acid (EDT A) buffer (pH 8). The 
mixture of DNA and bacteria was pulsed once at 2.5 kV with a setting of 
400 ohms and 25 JiFd. Following 1 h incubation in 1 ml S.O.c. medium 
(Gibco, BRL) at 37 °C, the bacteria were spread onto the indicator LB agar 
plates containing 5-bromo-4-chloro-3-indolyl-fl-D-galactoside, isopropyl 
jJ-D-thiogalactosidase, and 100 /lg/ml ampicillin or 50 Ilg/ml kanamycin. 
Estimation of Plasmid Survival and Mutation Frequency Estima-
tion of plasmid survival and mutation frequency was performed as indicated 
in Table I for the control ce ll line KR6058. Independent transfections in 
triplicate were performed for each UV dose to the plasmid. After harvesting 
the replicated plasmid from the human cells at 48 h, 5-450-IlL portions of 
the 1 ml bacterial transformation suspension were spread on selective agar 
plates (co/tllltll A). The total number of colonies on the ampicillin-contain-
ing plates (CO/tlmll B) was divided by the plated volume to determine the 
number of ampici llin-resistant colonies per ml (COhllllll F) . COltlmll G shows 
the mean ampicillin resistance (ampll) colonies per ml for all transfections ar 
a given UV dose to the plasmid. Colu Itt II H shows relative survival compared 
to the mean of the control untreated plasmid transfections. Co-transfectiotl 
with untreated pZ189K served as an internal standard. The ana logous calcu-
lations were made for the kanamycin resistance (kanll) colonies (CO/lllllll f) . 
The ratio of ampll colonies per ml (cO/tlmll F) to kanR colonies per ml (co/tlltt ll 
I) for each transfection is shown in co/ll/tllI J. The mean ratio (CO/l/1Il1l K) and 
normalized relative survival (colli Itt II L) are shown. 
The concentration of mutant colonies per ml was estimated for each plate 
by dividing the number of mutants (white or light blue colonies) (CO/UIIlIl D) 
by the volume plated (CO/tllllll A). The mutation frequency was calculated 
only in transfections for which 60 or more ampR colonies were counted. The 
ampR mutant colonies per ml calculated for each transfection (COltllllll M) was 
divided by the ampH colonies per ml (co/ulttll F) for that same transfection, to 
yield the mutation frequency (CO/tllllll N). The mean mutation frequency for 
all transfections at the same UV dose is calculated in COllltltll O. 
Statistical Analysis The mean and standard error of the mean were cal· 
culated for plasmid survival and mutation frequency from multiple indepen· 
dent transfections at each UV dose with each ce ll line. Comparisons of 
differences of means were made with the Student t test. Two-tailed p values 
are reported. The data were fitted to least-squares linear regression curvC\ 
using the Slidewrite Plus computer program. 
RESULTS 
Plasmid Survival 
Variability in Post-UV SUrlJiva l Measurements: Most of the earlie\ 
studies with the shuttle vector plasmid were performed usin 
human cells with large defects in DNA repair and cell survival wit~ 
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PLASMID HYPERMUTABILITY IN DNS 9 
consequent large differences in plasmid survival between the patient 
and normal. To detect possible small differences in plasmid survival 
between patients and normals, we co-transfected the UV-treated 
plasmid with an untreated internal standard plasmid to reduce the 
variability in the measurements. At each dose level of each experi-
ment with a given cell line the coefficient of variation of the counts 
obtained in two to three independent transfections was calculated. 
The mean coefficient of variation of the unadjusted counts (see 
Table I, cohllnll C) was 0.26 for 122 independent transfections using 
electroporation and 0.41 for 170 independent transfections using 
DEAE dextran. Normalization (see Table I, column L) reduced the 
mean coefficients of variation to 0.13 and 0.19, respectively. Thus 
the normalization reduced the variation in the plasmid survival 
estimation by about half. 
Normalization also reduced the instances in which survival mea-
surements increased with increasing UV dose rather than decreas-
ing, as expected. For example, in Table I, cohll1l1/ I unadjusted rela-
tive survival was 19% after 500 J/m2 but increased to 69% after 
1000 J/m2. Examination of the kanR colony counts (column C), 
however, indicates that the number of colonies was considerably 
greater in the 1000 J/m2 transfections, even for unirradiated plas-
mid. Accordingly, the normalized survival values (column L) were 
20% and 5%, respectively. There were nine separate experiments in 
which such survival inversions were observed with unadjusted mea-
surements and only one such case for the adjusted measurements. 
Consequently, for all subsequent analyses the data for normalized 
survival measurements are presented. 
Eleetroporatioll: Following introduction of UV -treated plasmid 
pSP189 in normal (GM606), DNS3BE, DNS5BE, or DNS6BE 
cells using electroporation, the normalized survival of UV -treated 
plasmid was reduced with increasing UV dose in all of the cells (Fig 
2A). Normalized plasmid survival in all the DNS cells at each UV 
dose was not less than that in the normal cells. In contrast, with 
DNA-repair-deficient XP-A cells (XP12BE) normalized post-UV 
plasmid survival was markedly reduced (Fig 2A). These data indi-
cate that unlike xeroderma pigmentosum cells, there is no evidence 
of reduced post-UV plasmid survival with the DNS cells. 
DEAE Dextral1: Transfection by DEAE dextran of UV -treated 
pSP189 (Fig 3A) did not change the relative results of the normal-
ized post-UV plasmid survival compared to those obtained by elec-
troporation (Fig 2A). N ormalized post-UV plasmid survival in 
DNS3BE, DNS5BE, and DNS6BE was not lower than that of four 
normals (GM606, KR6057, KR6058, and KR6060). As with elec-
troporation (Fig 2A), normalized post-UV pSP189 survival with 
the XP-A cells (XP12BE) was markedly reduced . 
Mutation Frequency 
Variability in Post-UV Plasmid Mutatioll Measurelllellts: In contrast 
to survival measurements, which are the ratio of counts between 
transfections with UV -treated plasmids and transfections with un-
treated plasmids, mutation frequency measurements (total colonies 
and mutant colonies) are obtained from the same transfection. Thus 
changes in the number of total colonies should be accompanied by 
changes in the number of mutant colonies. We found that the mean 
coefficient of variation of the mutation frequency for UV-treated 
plasmids (see Table I, COh,Ill'" 0) was 0.19 for 74 independent trans-
fections using electroporation and 0.11 for 85 independent trans-
fections using DEAE dextran. 
Electroporatioll: Following the introduction ofUV-treated plasmid 
pSP189 in normal (GM606), DNS3BE, DNS5BE, or DNS6BE 
cells using electroporation, the mutation frequency of UV -treated 
plasmid increased with increasing UV dose in all of the cells (Fig 
2B). Compared to the 110rmal cells the plasmid mutation frequency 
was significantly greater with the DNS3BE cells at 500 J/m2, with 
the DNS5BE cells at 100 J /m2, and with the DNS6BE cells at 250 
and 500 J/m2. The plasmid mutation frequency with the XP12BE 
cel ls was significantly greater than with the normal cells at 100 and 
250 J /m2• These data confirm the plasmid UV hypermutability in 
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Figure 2. Survival and mutagenesis ofUV-treated pSP189 transfected into 
normal, DNS, and XP-A cells by electroporation. pSP189 was treated with 
0-500 J/m2 UV, and transfected along with the untreated internal standard 
plasmid (pZ189K) by e1ectroporation into three DNS, one normal, and one 
XP-A lymphoblastoid cell linc. After 2 d the replicated plasmids were har-
vested and used to transform indicator bacteria to resistance to ampicillin or 
kanamycin. A) The normalized relative plasmid survival (see Table I) is 
plotted as a function ofuv dose to the plasmid. The mean ± SEM is shown. 
Solid diamond, DNS3BE (three to six transfections per point); solid triatlgle, 
DNS5BE (six to 16 transfections per point); solid square, DNS6BE (five to six 
transfections per point); open circle, GM606 (three to 15 transfections per 
point); solid circle, XP12BE (three to six transfections per point). Solid lines, 
DNS curves. B) The bacterial colonies obtained were analyzed for plasmids 
with wild-type supF gene (dark blue colonies) or mutated supF gene (white 
or light blue colonies). The mutation frequencies (see Table I) of the plas-
mids are plotted as a function ofUV dose to the plasmid. The mean ± SEM 
is shown. Details in Materials and Methods. 
the DNS cells; however, no single UV dose demonstrated the hy-
pennutability with all three DNS cell lines. 
Comparison of Trans feet ion Methods and Plasmids: We compared the 
post-UV mutation frequency using different methods of transfec-
tion and different plasmids because the earlier report [30] used UV-
treated pZ 189 transfected by use of DEAE dextran. In comparison 
to 500 11m2 UV-treated pSP189 transfected by electroporation (Fig 
2B), DEAE dextran transfection of500 J/m2 UV-treated pZ189 did 
not significantly alter the mutation frequency with the normal, 
DNS3BE, or DNS5BE cells (data not shown). In contrast, DEAE 
dextran transfection of UV-treated pSP189 significantly increased 
the plasmid mutation frequency with the DNS3BE and DNS5BE 
cells (p < 0.01) while not significantly increasing the mutation fre-
quency with the normal cells (Fig 3B). Because the comparison 
experiments indicated greater plasmid hypermutability in DNS 
cells by use of pSP189 and transfection by DEAE dextran, subse-
quent experiments used this protocol. 
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DEAE Dextran: Post-UV pSP189 mutation frequency was mea-
sured in three DNS (DNS3BE, DNS5BE, and DNS6BE), four nor-
mal (GM606, KR6057, KR6058, and KR6060) and one XP-A 
(XP12BE) cell line (Fig 3B). The mutagenesis of the UV-treated 
plasmid from DNS cells (DNS3BE, DNS5BE, and DNS6BE) was 
significantly greater at 1000 11m2 (10.95 ± 0.90%, n = 5 indepen-
dent transfections, p < 0.001; 7.81 ± 1.13%, n = 6, P < 0.001; 
7.85 ± 0.50%, n = 3, P < 0.001, respectively) than from the four 
normal lines (2.84 ± 0.11%, n = 23). At 500 11m2 DNS3BE and 
DNS5BE cells were also significantly hypermutable (5.40 ± 
0.40%, n = 8, P < 0.001 and 4.49 ± 0.37%, n = 7, P < 0.001) in 
comparison to four normals (1.48 ± 0.14%, n = 12). (DNS6BE 
was not tested at 500 11m2.) The XP-A lymphoblasts showed plas-
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Figure 3. Survival and mutagenesis ofUV-treated pSP189 transfected into 
normal, DNS, and XP-A cells by DEAE dextran. pSP189 was treated with 
0-1000 J/m2 UV and transfected along with the untreated internal standard 
plasmid (pZ189K) by DEAE dextran into three DNS, four normal, and one 
XP-A lymphoblastoid cell line. After 2 d the replicated plasmids were har-
vested and used to transform indicator bacteria to resistance to ampicillin or 
kanamycin. A) The normalized relative plasmid survival (see Table I) is 
plotted as a function ofUV dose to the plasmid. The mean ± SEM is shown. 
Solid diamond, DNS3BE (two to 15 transfections per point); solid triangle, 
DNS5BE (three to 12 transfections per point); solid square, DNS6BE (three 
transfections per point); open circle, GM606 (two to eight transfections per 
point); ope" triallgle, KR6057 (one to five transfections per point); 0pe'l sq'Mre, 
KR6058 (five to six transfections per point); open inverted triangle, KR6060 
(two to six transfections per point); solid circle, XP12BE (nine transfections 
per point). Solid lilies, DNS curves. B) The bacterial colonies obtained were 
analyzed for plasmids with wild-type supF gelle (dark blue colonies) or 
mutated supF gene (white or light blue colonies). The mutation frequencies 
(see Table I) of the plasmids are plotted as a function of UV dose to the 
plasmid. The mean ± SEM is shown. Details in Materials and Methods. 
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mid hypermutability, as reported previously [22-24). This plasmid 
hypermutability is in agreement with the cellular hypermutability 
of these DNS [16) and XP-A [35,36) cells. 
Spontaneous Mutations Untreated plasmid pSP189 was trans-
fected into normal, DNS, and XP-A cells by e1ectroporation (Fig 
2B) . The spontaneous plasmid mutation frequency was 0.02 ± 
0.01 % (n = 15) with the normal cells (GM606) but was signifi-
cantly elevated with the DNS3BE (0.12 ± 0.03%, n = 6, p < 
0.001) and DNS5BE (0.05 ± 0.01 %, n = 16, P = 0.037) cells. 
The spontaneous plasmid mutation frequency with pSP189 
transfected into four normal lines by DEAE dextran was similar, 
with a mean of 0.21 ± 0.02% (n = 21) (Fig 3B). This was not 
significantly different from the XP-A (mean 0.23%). The sponta-
neous plasmid mutation frequency was significantly elevated with 
three DNS lines (DNS3BE, 0.98 ± 0.08%, n = 23, P < 0.001; 
DNS5BE, 0.67 ± 0.05%, n = 13, P < 0.001; and DNS6BE, 
0.60 ± 0.01 %, n = 3, P < 0.001). 
DISCUSSION 
In as much as the clinical and histologic diagnostic criteria for DNS 
are in dispute (5), diagnosis based on only these features may be 
subject to question. Determination of the pathogenesis of DNS or 
detection oflaboratory abnormalities could supplement the diagno-
sis of DNS. However, the underlying abnormalities in DNS have 
not yet been determined. Different laboratories have provided evi-
dence for and against a susceptibility locus for familial melanoma/ 
DNS on chromosomes Ip [37 -43], 9p [44], 11 [45],6 [46], and a 
rearrangement of chromosomes 5 and 9 [47]. These different results 
suggest that there may be genetic heterogeneity among families 
with DNS and several different genes on different chromosomes 
may be responsible for familial melanoma/DNS. 
We used xeroderma pigmentosum as a model for human mela-
noma susceptibility [48]. Xeroderma pigmentosum yatients have 
sun sensitivity and an increased melanoma frequency [49] similar to 
that in familial DNS [8]. The diagnosis of xeroderma pigmentosum 
is based on clinical features plus laboratory detection of abnormali-
ties including cellular UV hypersensitivity, hypermutability, ele-
vated UV-induced sister chromatid exchanges, and defective DNA 
repair [48]. Like xeroderma pigmentosum, cultured skin fibroblasts 
or lymphoblastoid lines from patients with DNS have been reported 
to be hypersensitive to killing by UV [12-14]; however, this was 
not found in cells from all DNS patients [15,16]. 
Like familial DNS, the variant form of xeroderma pigmentosum 
has the clinical features of numerous pigmented lesions and in-
creased melanoma frequency along with normal or nearly normal 
post-UV cell survival, normal unscheduled DNA synthesis (a mea-
sure of DNA repair), and cellular UV hypermutability [36,48,50] . 
Plasmid UV hypermutability with normal UV survival has also 
been reported with cells from a xeroderma pigmentosum variant 
patient [27,51]. Some of these same clinical and laboratory features 
are found in familial DNS. Perera et al [16] reported that lympho-
blastoid cell lines from three DNS patients had a two- to three-fold 
greater frequency of UV -induced mutants (6-thioguanine-
resistant cells) per clonable cell than did three normal lines. Howell 
et al [13] reported that fibroblasts from a patient with hereditary 
cutaneous malignant melanoma were abnormally sensitive to the 
mutagenic effect of simulated sunlight. Sanford et al [52] reported 
persistent chromosome breakage following x-ray exposure of fibro-
blasts or lymphocytes ill vitro in the G2 phase of the cell cycle. Jung 
et al [17] found that fibroblasts from 12 DNS patients had abnor-
mally increased rates of sister chromatid exchanges following expo-
sure to UV. Most studies of DNA repair in cells from patients with 
DNS were normal [16]; however, Roth et al [53] reported reduced 
removal of antigenic thymine dimers after UV exposure in fibro-
blasts from seven of eight DNS patients. 
. Shuttle vector plasmids have recently been developed for assess-
Ing UV hypersensitivity and UV mutagenesis in human cells. Ab-
normalities have been reported in cells from patients with xero-
derma pigmentosum [20-27], Cockayne syndrome [28] , 
trichothiodystrophy (29), and in apparently normal individuals 
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Table II. Comparison of Post-UV Plasmid Survival and 
Mutation Frequency in Xeroderma Pigmentosum, Dysplastic 
Nevus syndrome, and Normal Lymphoblastoid Cell Lines 
Dextran 
Cells 
XP-A 
DNS3BE 
DNS5BE 
DNS6BE 
GM606 
KR6057 
KR6058 
KR6060 
Survival Do 
(]'m-2), 
92 
393 
426 
277 
277 
350 
349 
367 
• Calculated from Fig 3A. 
• Calculated from Fig 3B. 
, Calculated from Fig 2A. 
J Calculated from Fig 2B. 
t nt, not tested. 
Mutation 
Frequency 
At Dob 
1.78% 
4.3% 
3.6% 
2.6% 
1.0% 
1.2% 
1.1 % 
1.1% 
Electroporation 
Survival Do 
(J'm- 2) , 
49 
332 
240 
254 
159 
nt' 
nt 
nt 
Mutation 
Frequency 
AtD/ 
0.8% 
2.2% 
0.9% 
1.4% 
0.4% 
nt 
nt 
nt 
with basal cell carcinomas [54] . Seetharam et al [30] reported UV 
hypermutability in lymphoblastoid cells from a patient with DNS 
(DNS6BE) using the shuttle vector pZ189. To develop a reproduc-
ible laboratory test for possible confirmation of the diagnosis of 
DNS, we made several modifications in the method used by Seeth-
aram et al [30] . 1) We used a different shuttle vector plasmid, 
pSP189 [32], for assessing mutagenesis. This plasmid results in a 
higher level ofuv -induced mutagenesis than pZ189. 2) We used a 
second shuttle vector, pZ189K, as an internal standard. This plas-
mid has the gene for kanamycin resistance instead of the gene for 
ampicillin resistance. By use of this internal standard we were able 
to reduce the variation of the plasmid survival measurements by 
about half compared to measurements without the internal stan-
dard. 3) We found that transfection with DEAE dextran, as used by 
Seetharam et al [30], resulted in greater plasmid UV hypermutability 
in DNS cells than did transfection by electroporation despite a 
higher colony yield with e1ectroporation. Interestingly, UV-in-
duced mutations with pSP189 were increased by transfection with 
DEAE dextran relative to transfection with e1ectroporation only in 
DNS cells, not in normal and XP-A cells. The mechanism of this 
dextran effect is unknown. DEAE dextran itself does not induce 
mutations directly in DNA [55] . 
The variability of normalized colony counts was about 15 - 20% 
of the mean and that of mutation measurements was about 10 - 20% 
of the mean. Table II compares the calculated Do (the dose at 37% 
plasmid survival, representing one lethal hit per plasmid assuming 
Poisson inactivation kinetics) in each cell line (from Fig 2A and 3A) 
to the calculated mutation frequency (from Fig 2B and 3B) at that 
dose for both transfection methods. Table II indicates that the 
XP-A, but not the DNS cell lines, showed reduced plasmid survival. 
However, the XP-A line and all three DNS lines showed plasmid 
hypermutability at their respective Do doses in comparison to the 
normal lines. 
These results suggest that UV hypermutability of pSP189 with 
normal UV survival in our system using DEAE dextran may provide 
a marker of genetic susceptibility to familial DNS. Unlike the cell 
mutation assay by 6-thioguanine resistance [16], the shuttle vector 
system using pSP189 is rapid (48-h incubation instead of several 
weeks incubation) and does not involve direct mutagen treatment of 
the cells. This plasmid assay can also be used in phytohemaggluti-
nin- and interleukin 2-stimulated human T lymphocytes [24]. Our 
method and the results presented here may form the basis of a 
possible laboratory test to aid in the diagnosis of DNS and in other 
disorders with cellular UV hypersensitivity or UV hypermutability, 
such as xeroderma pigmentosum [20-27]' Cockayne syndrome 
[28], or trichothiodystrophy [29]. We plan on assessing the validity 
of this assay by testing multiple family members in kind reds with 
familial DNS and normal controls of different ages. 
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